Comparing the effectiveness of two cell products and triamcinolone drug in the treatment of lichen planopillaris

Phase 1

Recruiting

• Conditions: ichen Planopilaris.; Cicatricial alopecia [scarring hair loss]

• Registration Number: IRCT20200127046282N29
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age between 18-60 years
Lichen planopilaris disease has been proven

Exclusion Criteria

breastfeeding
pregnancy
Infectious diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to treatment. Timepoint: 0 and 6 months after the start of the study. Method of measurement: Lichen plano pilaris activity index.;The amount of hair loss. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Trichoscan.

Secondary Outcome Measures

Name	Time	Method
The level of satisfaction with treatment qualitatively. Timepoint: 2 and 6 months after the start of treatment. Method of measurement: In the qualitative questionnaire (excellent effect, good, medium, low, ineffective).;Side effects. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Questionnaire and visit.;Effectiveness. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Questionnaire and visit.